HePTP activators are chemicals that target the hematopoietic tyrosine phosphatase (HePTP) enzyme, which is a non-receptor type protein tyrosine phosphatase. The primary function of HePTP is to dephosphorylate specific tyrosine residues on target proteins, an action that alters the activity of these proteins and thus the signaling pathways in which they are involved. HePTP is known to interact with and regulate members of the mitogen-activated protein kinase (MAPK) family, such as ERK and p38, which are key players in the regulation of cell proliferation, differentiation, and responses to various stimuli. Activators of HePTP enhance the phosphatase activity of HePTP, leading to an increased dephosphorylation rate of its substrates. By modulating the activity of HePTP, these activators can influence the MAPK signaling pathways and the downstream cellular responses. The design of such activators requires a comprehensive understanding of the enzyme's active site and the molecular dynamics that govern substrate recognition and catalysis.
The development of HePTP activators is a complex endeavor that involves a multi-faceted approach to identify and optimize compounds capable of increasing the enzyme's catalytic action. This typically involves the use of high-throughput screening techniques to evaluate a large library of potential activators, followed by detailed structure-activity relationship (SAR) studies to refine the efficacy and specificity of the compounds. Researchers employ various biochemical and biophysical methods to assess how these activators bind to HePTP, including X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational docking simulations. These sophisticated techniques provide insights into the molecular interactions at play and help in the design of molecules that can effectively stabilize the active conformation of the enzyme or promote its interaction with its substrates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is known to invigorate adenylate cyclase, which in turn amplifies intracellular cAMP levels. This could indirectly trigger an increase in HePTP expression as part of a wider transcriptional response to elevated cAMP levels. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
As a potent regulator of gene expression and cell differentiation, retinoic acid could potentially stimulate HePTP expression as part of its crucial role in fostering the differentiation of T cells, cells where HePTP is predominantly expressed. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, could potentially modulate HePTP expression, as it is known to regulate immune responses and inflammation. These are processes in which HePTP is intricately involved, thereby making it plausible that changes in these processes could alter HePTP expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol is a hormone known to affect the immune system. It may indirectly influence HePTP expression by triggering changes in the overall state of immune cells, potentially leading to an increase in HePTP levels. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol is involved in the immune system's functionality. It could potentially stimulate HePTP expression by modifying T cell function, which might necessitate an enhanced expression of associated proteins like HePTP. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 could potentially stimulate HePTP expression indirectly by modulating immune responses due to its known role in inflammation and immune modulation. Changes in these processes could drive the need for increased HePTP expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, could potentially enhance HePTP expression by promoting a more relaxed chromatin state. This would make the HePTP gene more accessible for transcription, potentially leading to an upsurge in HePTP levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known for its anti-inflammatory properties. It could potentially stimulate HePTP expression as part of a broader anti-inflammatory response, given the role of HePTP in immune signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
(-)-Epigallocatechin Gallate, a compound prevalent in green tea, can affect various cellular processes, including those related to immune function. It might potentially induce an increase in HePTP expression by modifying the activity of T cells, in which HePTP is heavily involved. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is lauded for its antioxidant and anti-inflammatory properties. It might potentially stimulate the expression of HePTP as part of a broader anti-inflammatory response, considering the key role HePTP plays in immune signaling. | ||||||